针对原发性局灶性多汗症症状开发的焦虑量表的可靠性和有效性。

IF 2.3 4区 医学 Q2 PSYCHIATRY
Sayaka Ogawa, Jun Tayama, Hiroyuki Murota, Masakazu Kobayashi, Hirohisa Kinoshita, Seiko Nakamichi
{"title":"针对原发性局灶性多汗症症状开发的焦虑量表的可靠性和有效性。","authors":"Sayaka Ogawa, Jun Tayama, Hiroyuki Murota, Masakazu Kobayashi, Hirohisa Kinoshita, Seiko Nakamichi","doi":"10.1186/s13030-024-00310-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with primary focal hyperhidrosis (hyperhidrosis) are known to have higher levels of anxiety induced by sweating than those who do not. However, in hyperhidrosis, no scale has been developed to measure anxiety specific to hyperhidrosis symptoms. Therefore, this study aimed to develop an anxiety scale specific to hyperhidrosis symptoms (ASSHS) and to verify its reliability and validity.</p><p><strong>Methods: </strong>Based on previous studies on hyperhidrosis and a preliminary survey conducted with 26 university students who met the diagnostic criteria for hyperhidrosis, 40 items that adequately reflected anxiety specific to hyperhidrosis symptoms were obtained. A survey was done to examine the internal consistency and validity of the our developed ASSHS. In total, 1,207 participants (680 male and 527 female; mean age ± standard deviation 18.7 ± 0.9 years) were included. A second survey (re-survey) was conducted three weeks later to verify the reliability. It included 201 participants (85 male and 116 female; mean age ± standard deviation 18.6 ± 0.7 years). The survey items included (1) the diagnostic criteria for hyperhidrosis, (2) our anxiety scale developed for primary focal hyperhidrosis symptoms (ASSHS), (3) Hyperhidrosis Disease Severity Scale (HDSS), (4) State-Trait Anxiety Inventory (STAI), (5) Hospital Anxiety and Depression Scale (HADS), (6) Dermatology Life Quality Index (DLQI), and (7) presence of anxiety induced by sweating.</p><p><strong>Results: </strong>The results of the factor analysis revealed 10 items with one factor, \"anxiety specific to hyperhidrosis symptoms.\" The alpha coefficient of the ASSHS was α = 0.94. The correlation coefficient between the scores at re-test was r = 0.75. A moderate positive correlation was found between the ASSHS, HDSS (r = 0.53), and anxiety induced by sweating (r = 0.47) (all p < 0.001). Additionally, participants with hyperhidrosis symptoms had significantly higher ASSHS scores than did those without hyperhidrosis symptoms (p < 0.001). Those with mild/moderate hyperhidrosis and those with severe hyperhidrosis had significantly higher the ASSHS scores than did those without hyperhidrosis (p < 0.001).</p><p><strong>Conclusions: </strong>This scale has sufficient reliability and validity as an instrument to measure anxiety specific to hyperhidrosis symptoms.</p>","PeriodicalId":9027,"journal":{"name":"BioPsychoSocial Medicine","volume":"18 1","pages":"14"},"PeriodicalIF":2.3000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149174/pdf/","citationCount":"0","resultStr":"{\"title\":\"The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms.\",\"authors\":\"Sayaka Ogawa, Jun Tayama, Hiroyuki Murota, Masakazu Kobayashi, Hirohisa Kinoshita, Seiko Nakamichi\",\"doi\":\"10.1186/s13030-024-00310-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients with primary focal hyperhidrosis (hyperhidrosis) are known to have higher levels of anxiety induced by sweating than those who do not. However, in hyperhidrosis, no scale has been developed to measure anxiety specific to hyperhidrosis symptoms. Therefore, this study aimed to develop an anxiety scale specific to hyperhidrosis symptoms (ASSHS) and to verify its reliability and validity.</p><p><strong>Methods: </strong>Based on previous studies on hyperhidrosis and a preliminary survey conducted with 26 university students who met the diagnostic criteria for hyperhidrosis, 40 items that adequately reflected anxiety specific to hyperhidrosis symptoms were obtained. A survey was done to examine the internal consistency and validity of the our developed ASSHS. In total, 1,207 participants (680 male and 527 female; mean age ± standard deviation 18.7 ± 0.9 years) were included. A second survey (re-survey) was conducted three weeks later to verify the reliability. It included 201 participants (85 male and 116 female; mean age ± standard deviation 18.6 ± 0.7 years). The survey items included (1) the diagnostic criteria for hyperhidrosis, (2) our anxiety scale developed for primary focal hyperhidrosis symptoms (ASSHS), (3) Hyperhidrosis Disease Severity Scale (HDSS), (4) State-Trait Anxiety Inventory (STAI), (5) Hospital Anxiety and Depression Scale (HADS), (6) Dermatology Life Quality Index (DLQI), and (7) presence of anxiety induced by sweating.</p><p><strong>Results: </strong>The results of the factor analysis revealed 10 items with one factor, \\\"anxiety specific to hyperhidrosis symptoms.\\\" The alpha coefficient of the ASSHS was α = 0.94. The correlation coefficient between the scores at re-test was r = 0.75. A moderate positive correlation was found between the ASSHS, HDSS (r = 0.53), and anxiety induced by sweating (r = 0.47) (all p < 0.001). Additionally, participants with hyperhidrosis symptoms had significantly higher ASSHS scores than did those without hyperhidrosis symptoms (p < 0.001). Those with mild/moderate hyperhidrosis and those with severe hyperhidrosis had significantly higher the ASSHS scores than did those without hyperhidrosis (p < 0.001).</p><p><strong>Conclusions: </strong>This scale has sufficient reliability and validity as an instrument to measure anxiety specific to hyperhidrosis symptoms.</p>\",\"PeriodicalId\":9027,\"journal\":{\"name\":\"BioPsychoSocial Medicine\",\"volume\":\"18 1\",\"pages\":\"14\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149174/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BioPsychoSocial Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13030-024-00310-y\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BioPsychoSocial Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13030-024-00310-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景:众所周知,原发性局灶性多汗症(多汗症)患者因出汗而产生的焦虑程度高于非多汗症患者。然而,在多汗症患者中,尚未开发出专门针对多汗症症状的焦虑量表。因此,本研究旨在开发一种专门针对多汗症症状的焦虑量表(ASSHS),并验证其可靠性和有效性:根据以往有关多汗症的研究以及对 26 名符合多汗症诊断标准的大学生进行的初步调查,获得了 40 个能充分反映多汗症症状特有焦虑的项目。为了检验我们开发的 ASSHS 的内部一致性和有效性,我们进行了一项调查。共有 1207 名参与者(男性 680 人,女性 527 人;平均年龄(标准差)为 18.7 ± 0.9 岁)参与了调查。三周后进行了第二次调查(重新调查),以验证其可靠性。该调查包括 201 名参与者(男性 85 人,女性 116 人;平均年龄(标准差)为 18.6 ± 0.7 岁)。调查项目包括:(1)多汗症诊断标准;(2)我们针对原发性局灶性多汗症症状开发的焦虑量表(ASSHS);(3)多汗症疾病严重程度量表(HDSS);(4)状态-特质焦虑量表(STAI);(5)医院焦虑和抑郁量表(HADS);(6)皮肤科生活质量指数(DLQI);(7)出汗引起的焦虑:因子分析结果显示,10 个条目包含一个因子,即 "多汗症症状特有的焦虑"。ASSHS 的α系数为 α = 0.94。复测得分之间的相关系数为 r = 0.75。在 ASSHS、HDSS(r = 0.53)和出汗引起的焦虑(r = 0.47)之间发现了中等程度的正相关(均为 p 结论):该量表具有足够的可靠性和有效性,可用于测量多汗症症状所特有的焦虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms.

Background: Patients with primary focal hyperhidrosis (hyperhidrosis) are known to have higher levels of anxiety induced by sweating than those who do not. However, in hyperhidrosis, no scale has been developed to measure anxiety specific to hyperhidrosis symptoms. Therefore, this study aimed to develop an anxiety scale specific to hyperhidrosis symptoms (ASSHS) and to verify its reliability and validity.

Methods: Based on previous studies on hyperhidrosis and a preliminary survey conducted with 26 university students who met the diagnostic criteria for hyperhidrosis, 40 items that adequately reflected anxiety specific to hyperhidrosis symptoms were obtained. A survey was done to examine the internal consistency and validity of the our developed ASSHS. In total, 1,207 participants (680 male and 527 female; mean age ± standard deviation 18.7 ± 0.9 years) were included. A second survey (re-survey) was conducted three weeks later to verify the reliability. It included 201 participants (85 male and 116 female; mean age ± standard deviation 18.6 ± 0.7 years). The survey items included (1) the diagnostic criteria for hyperhidrosis, (2) our anxiety scale developed for primary focal hyperhidrosis symptoms (ASSHS), (3) Hyperhidrosis Disease Severity Scale (HDSS), (4) State-Trait Anxiety Inventory (STAI), (5) Hospital Anxiety and Depression Scale (HADS), (6) Dermatology Life Quality Index (DLQI), and (7) presence of anxiety induced by sweating.

Results: The results of the factor analysis revealed 10 items with one factor, "anxiety specific to hyperhidrosis symptoms." The alpha coefficient of the ASSHS was α = 0.94. The correlation coefficient between the scores at re-test was r = 0.75. A moderate positive correlation was found between the ASSHS, HDSS (r = 0.53), and anxiety induced by sweating (r = 0.47) (all p < 0.001). Additionally, participants with hyperhidrosis symptoms had significantly higher ASSHS scores than did those without hyperhidrosis symptoms (p < 0.001). Those with mild/moderate hyperhidrosis and those with severe hyperhidrosis had significantly higher the ASSHS scores than did those without hyperhidrosis (p < 0.001).

Conclusions: This scale has sufficient reliability and validity as an instrument to measure anxiety specific to hyperhidrosis symptoms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
23
审稿时长
18 weeks
期刊介绍: BioPsychoSocial Medicine is an open access, peer-reviewed online journal that encompasses all aspects of the interrelationships between the biological, psychological, social, and behavioral factors of health and illness. BioPsychoSocial Medicine is the official journal of the Japanese Society of Psychosomatic Medicine, and publishes research on psychosomatic disorders and diseases that are characterized by objective organic changes and/or functional changes that could be induced, progressed, aggravated, or exacerbated by psychological, social, and/or behavioral factors and their associated psychosomatic treatments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信